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Edited by Vladimir SkulachevAbstract Bax insertion into the mitochondrial outer membrane
is essential for the implementation of apoptosis. However, little
is known about the ﬁrst stage of Bax integration into the mito-
chondrial outer membrane. We have recently shown that
TOM22, a mitochondrial outer membrane receptor, is important
for insertion, although other reports have suggested that only
mitochondrial lipids are involved in this process. Here, we show
that monomers, but not dimers, of Bax require the presence of
TOM22 and TOM40 to integrate into mitochondria. In addition
we show that once inserted into the membrane, Bax can act as a
receptor for cytosolic Bax.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Autocatalysis1. Introduction
Apoptosis is a cell death program, which is essential to many
aspects of development and life of multi-cellular organisms
[1,2]. The insertion of Bax, a pro-apoptotic member of the
Bcl-2 family, into the mitochondrial outer membrane is closely
associated with the release into the cytosol of several inter-
membrane space proteins, which are instrumental to the execu-
tion phase of the apoptotic program [3]. Little is known about
mechanisms implicated in the insertion of Bax into mitochon-
dria [3]. It has recently been shown that Bax interacts with the
translocase of the outer mitochondrial membrane (TOM) com-
plex, the machinery responsible for the translocation of nucle-
ar-encoded proteins through the outer membrane [4,5].
Bax oligomerization accompanies the insertion of Bax into
the mitochondria [3] and the forced dimerization of Bax is suf-
ﬁcient to trigger its mitochondrial insertion [6]. However, it is
not known if the oligomerization of Bax occurs prior to or at
the moment of its interaction with mitochondria. Annis et al.Abbreviations: dBax, dimeric Bax; IVT, in vitro translated; mBax,
monomeric Bax; RFP, red ﬂuorescent protein; TOM, translocase of
the outer mitochondrial membrane; PBR, peripheral benzodiazepine
receptor; VDAC, voltage dependent anionic channel
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doi:10.1016/j.febslet.2008.07.047[7] have suggested that the Bax-induced membrane permeabi-
lization results from oligomerization of transmembrane mono-
mers rather than an insertion as preformed oligomers. On the
other hand, dimers of Bax can be generated in the cytosol in
H2O2-treated cells, showing that dimerization in the cytosol
may exist under certain conditions [8].
In this work, we show thatmonomers and dimers of Bax inter-
actdiﬀerentlywithmitochondria in a cell-free assay, andhypoth-
esize an autocatalytic model for the membrane insertion of Bax.2. Materials and methods
2.1. Reagents
Unless otherwise stated all reagents used in this study were from Sig-
ma–Aldrich (St. Quentin, Fallavier, France). All cell culture material
was obtained from Invitrogen (Cergy Pontoise, France). Commercial
antibodies used were described in [4]. The list of antibody and their
provenance are listed in Fig. S1.
2.2. Acellular binding of in vitro translated (IVT) proteins to
mitochondria, trypsin treatments
Mitochondria were isolated from rat liver and the association of
[35S-Met]-IVT proteins were performed as previously described [9].
Trypsin treatment of mitochondria, alkaline extraction of mitochon-
drial proteins and competition experiments for the binding of IVT pro-
teins to mitochondria in the presence of peptides were performed as
described previously [4,9]. [35S]IVT-proteins present in the mitochon-
drial pellet were analyzed by P-Imager (Amersham Biosciences) and
quantiﬁed with ImageJ as described earlier [9].
2.3. pH-induced dimerization of Bax and tBid-induced activation of Bax
The pH was adjusted with NaOH or HCl as described earlier [10].
Equimolar IVT-Bax and His-tagged-tBid were incubated for
120 min. Bax was isolated after incubation with Ni-NTA resin (Qia-
gen), then centrifuged as described in [11]. The resulting supernatant
was used as a source of activated Bax after analysis with the anti-active
form Bax antibody (6A7) to determine its activation [11].
2.4. Immunoprecipitation and microinjections
Immunoprecipitation was performed as described in [4]. Microinjec-
tion experiments were performed as described in [12] using monomeric
Bax (mBax) or dimeric Bax (dBax) prepared from His-tagged recombi-
nant Bax, puriﬁed as described in [13].3. Results
3.1. Diﬀerences in the mitochondrial association of mBax and
dBax
We induced the dimerization of Bax following a recently
published protocol in which mBax was separated from dBaxblished by Elsevier B.V. All rights reserved.
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molecular weight cut-oﬀ after incubation at pH 7.8 [10]. To
conﬁrm the pH-induced dimerization, IVT-Bax incubated at
pH 7.4 or pH 7.8 was analyzed under non-denaturing PAGE
followed by auto-radiography (Fig. 1A).
IVT-mBax and -dBax were incubated with isolated rat liver
mitochondria for 30 min at 37 C and the presence of Bax was
analyzed in the pellet to monitor its mitochondrial association
as previously described [9]. As shown in Fig. 1B, mBax did notFig. 1. Diﬀerential interaction of mBax and dBax with isolated rat liver mitoc
mBax and dBax, the presence of [35S]IVT-Baxa was analyzed in non-denatu
mitochondria. [35S]IVT-mBax or -dBax, obtained as in A, were incubated wit
or not with tBid and in the presence of equimolar concentration of IVT-hexo
were fused to the cytosolic protein RFP (red ﬂuorescent protein): Ha1-R
mitochondria were recovered by centrifugation and the presence of [35S]IVT
imager). i = 25% of the original input of IVT proteins. This ﬁgure illustrates
antibodies of the interaction of mBax and dBax with mitochondria. The assoc
presence or in the absence of the antibodies against several mitochondrial pr
to the addition of IVT-proteins. [35S]IVT-proteins present in the mitochon
determine membrane insertion of Bax. Analysis of the association of Bax as w
were calculated from at least ﬁve independent experiments. The liberation of
obtained as described above. Illustrated graph has been calculated from Ima
independent experiments. (D) The liberation of cyt c from mitochondrial a
mitochondrial supernatant after 60 min of incubation. Mitochondrial cyt c re
mitochondria were analyzed by immunoblots. Results were calculated fromassociate with mitochondria unless activated by an apoptotic
stimulus such as truncated Bid (tBid) as described earlier [9].
On the other hand, the forced dimerization of Bax was suﬃ-
cient to trigger its association with mitochondria (Fig. 1B),
as previously reported [6]. The association of dBax with mito-
chondria was not modiﬁed by a prior incubation with tBid
(Fig. 1B). We have shown that the ﬁrst alpha helix (Ha1) of
Bax contained a mitochondrial addressing signal and that
the over-expression of a construct in which the Ha1 was fusedhondria. (A) Activation of mBax and dBax by pH. In order to visualize
ring PAGE. (B) Inhibition of the interaction of mBax and dBax with
h 50 lg rat liver mitochondria in standard import buﬀer after activation
kinase or chimeras in which the two putative addressing signals of Bax
FP or RFP-Ha9. At the end of the incubation (1 h at 37 C) the
-Baxa was analyzed on SDS–PAGE followed by phosphoimager (P-
the results of at least ﬁve independent experiments. (C) Inhibition by
iation mBax and dBax with rat liver mitochondria was performed in the
oteins (15 lg) were incubated with mitochondria at 37 C, 10 min prior
drial pellet were analyzed by P-Imager after an alkaline treatment to
ell as its insertion into the outer membrane was performed as in B. Data
cyt c was assessed by immunoblot analysis performed with supernatant
geJ quantiﬁcation of immunoblots and is representative of at least ﬁve
fter binding of mBaxtBid was analyzed by immunoblot analysis of the
leased into the supernatants from untreated, dBax- or mBaxtBid-treated
at least three independent experiments (expressed as means ± S.D.).
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dent apoptosis in vitro [9]. As shown in Fig. 1B, the mitochon-
drial association of tBid-activated mBax (mBaxtBid) in the cell-
free assay was inhibited by the over-expression of Ha1-RFP
but not by RFP-Ha9, a similar construct in which the Ha9
of Bax, another putative Bax mitochondrial signal, was fused
to the C-terminus of RFP. As illustrated in Fig. 1B, the asso-
ciation of mBaxtBid was not aﬀected by an excess of BSA or
IVT-Hexokinase II, an enzyme that inserts into the mitochon-
drial outer membrane through an interaction of its Ha1 with
the voltage dependent anionic channel (VDAC) [14]. Of note,
neither of the above-mentioned proteins aﬀected the associa-
tion of dBax with mitochondria even after its prior treatment
with tBid (Fig. 1B).
We have shown that the association of Baxa with mitochon-
dria occurs through the interaction of the Ha1 of Bax with
TOM22 [4]. To address the question of the involvement of pro-
tein receptors of the mitochondrial outer membrane with
mBax and dBax, we saturated isolated rat liver mitochondria
with antibodies raised against members of the TOM complex
(TOM20, TOM22 or TOM40) or against outer mitochondrialFig. 2. mBax and dBax does not require protease sensitive mitochondrial com
TOM22 and TOM40. Cross-linking experiments were performed using mBax
point, the cross-linked products were immunoprecipitated with anti-Bax a
immunoblots. i = 25% of the original input. Results were calculated from at
Association of mBax and dBax after trypsin treatment of mitochondria. Puri
concentrations of trypsin for 30 min at 4 C before neutralization of the enzy
added to mitochondria, control (0) or treated with 5 or 50 lg/ml trypsin. i2
illustrates the results of at least ﬁve independent experiments. The eﬃcacy and
of two mitochondrial outer membrane proteins (TOM22 and PBR) and F1
TOM22 and anti-TOM40 antibodies on apoptosis induced by the microinje
TOM40 protected BdGBM cells against mBaxtBid- but not dBax-induced ceproteins such as the peripheral benzodiazepine receptor,
(PBR), Metaxins (MTX-1 and -2) or mitochondrial porins
(VDAC-1 and -2) since these proteins have been implicated
in the mitochondrial docking of members of the Bcl-2 family
or in the control of apoptosis [4,5,14–18]. IVT-mBax or -dBax
were incubated with isolated rat liver mitochondria in the pres-
ence of saturating concentrations of antibodies raised against
the above-mentioned proteins. As described earlier [4], mBaxt-
Bid-triggered insertion was dependent on its interaction with
TOM22 (Fig. 1C). Other proteins (including TOM40) had no
inﬂuence on the association of mBaxtBid with mitochondria.
Conversely, we found that dBax association and/or insertion
was not dependent on any of the proteins analyzed (Fig. 1C).
In the same assay, we also analyzed mBaxtBid and dBax
membrane insertion after an alkaline treatment of mitochon-
dria [4]. As illustrated in Fig. 1C, both anti-TOM22 and
anti-TOM40 antibodies inhibited mBaxtBid insertion into the
mitochondria, in the former case probably because of an inhi-
bition of the association, while in the latter case this inhibition
appears to be speciﬁc to the insertion step. These results
suggest that TOM22 is involved in mBax association withponents. (A) Time-course of the association of mBaxtBid and dBax with
tBid or dBax incubated in the presence of 50 lg mitochondria. At each
ntibody and the presence of Bax, TOM40 or TOM22 analyzed by
least three independent experiments (expressed as means ± S.D.). (B)
ﬁed rat liver mitochondria (50 lg protein) were treated with increasing
matic activity as described in Ref. [4]. [35S]IVT-mBaxtBid or -dBax were
5%: 25% of the original input of [35S]IVT-proteins. This immunoblot
the speciﬁcity of the treatment were assessed by the protease sensitivity
-ATPase a mitochondrial inner membrane protein. (C) Eﬀect of anti-
ction of mBaxtBid or dBax. The antibodies raised against TOM22 and
ll death.
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tion. On the other hand, none of the other mitochondrial
membrane proteins analyzed had an eﬀect on dBax insertion
into mitochondria (Fig. 1C). However, it should be noted that
dBax insertion was more sensitive to an alkaline treatment.
These results suggest that most dBax was not membrane
embedded and thus that dBax mitochondrial insertion was
not as eﬃcient as that of mBaxtBid. Of note, the addition of
tBid did not aﬀect this process (data not shown).
Next, we compared the apoptogenic properties of mBaxtBid
and dBax by measuring the release of cytochrome c (cyt c)
from rat liver mitochondria into the supernatant after incuba-HisTag
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response to STS-induced apoptosis (20 lM) in BdGBM cells expressing BaxF
presence of BaxFlag and BaxL26GHisTag in non-immunoprecipitated cytosoli
subcelluar fractionation [9] to perform anti-Flag immunoprecipitations from
tations were performed using the Catch & Release v2.0 reversible immunoprec
were performed in the presence of ExactaCruz (SantaCruz).tion with mBaxtBid and dBax for 60 min as this period corre-
sponds to the peak in the release of cyt c and to the
maximum association of these proteins with mitochondria
(data not shown). As shown in Fig. 1C, the absence of mBax
tBid insertion into the mitochondria due to the incubation with
anti-TOM40 precludes the release of cyt c from mitochondria.
On the other hand, the dBax-induced liberation of cyt c was
unaﬀected by anti-TOM40, as this antibody had no eﬀect on
the association/insertion of dBax. It should be noted that the
release of cyt c in the presence of dBax was not as strong as
that observed with mBaxtBid (P < 0.0001). This suggests that
the presence of TOM22 and TOM40 favors but is not neces-W
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ree independent experiments. (D) Subcellular redistribution of mBax in
lag and BaxL26GHisTag. Ct represents a loading control illustrating the
c fraction from non-apoptotic cells. At each time point, we performed
the mitochondrial (M) and cytosolic (C) fractions. Immunoprecipi-
ipitation system (Millipore) and 4 lg anti-Flag antibody. Immunoblots
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ﬁrms that dBax is not as eﬃcient as mBax in mitochondrial
permeabilization (Fig. 1D).
Our results suggest that both TOM22 and TOM40 interact
with mBaxtBid. We thus examined the mitochondrial integra-
tion of mBaxtBid and dBax by monitoring the time course of
their interaction with TOM22 and TOM40 by immunoprecip-
itation using an anti-Bax antibody. As shown in Fig. 2A,
mBaxtBid bound signiﬁcantly more to TOM22 than to
TOM40 after 10 and 20 min of incubation (P = 0.0305 and
P = 0.0354, respectively), while no diﬀerence was observed
after 30 min of incubation (P = 0.1304). We did not observe
any association between dBax and TOM22 or TOM40 under
similar conditions (Fig. 2A).
To address the question of whether the cytosolic domains of
mitochondrial outer membrane proteins are implicated in
mBaxtBid and dBax mitochondrial addressing and insertion,
mitochondria were treated with a mild trypsin treatment as de-
scribed earlier [4], using the presence of protease-sensitive pro-
teins such as PBR and TOM22 or protease-protected proteins
such as F1-ATPase as controls (Fig. 2B). The association of
mBaxtBid with mitochondria was inhibited by a low concentra-
tion of trypsin (Fig. 2B) while that of dBax was not aﬀected,
even at high concentrations of trypsin (Fig. 2B). These results
show that dBax utilize receptors of diﬀerent nature than
mBaxtBid.
3.2. Eﬀect of microinjection of anti-TOM22 or anti-TOM40
antibodies on mBaxtBid- and dBax-induced apoptosis in vitro
The requirement for TOM components was further substan-
tiated in experiments in which mBaxtBid and dBax were co-in-
jected with antibodies raised against TOM22 and TOM40 into
Bax-deﬁcient GBM (BdGBM) cells. Cell death was monitored
by morphological analyses and quantiﬁed as previously de-
scribed [4]. Microinjection of anti-TOM antibodies inhibited
mBaxtBid-induced apoptosis but had no consequence on the
apoptosis induced by dBax. This inhibition was speciﬁc since
the microinjection of control IgG (Fig. 2C) had no eﬀect onFig. 4. A model for Bax insertion and oligomerization in mitochondria. (A) B
The induction of apoptosis triggers a change in the conformation of Bax that
under a ligand conformation (BaxL) and is capable of interacting with TOM
with TOM40, Bax becomes a receptor (BaxR) for other BaxL molecules. Thi
mitochondrial outer membrane with the likely cooperation of membrane lipid
oligomerization, although this does not lead to an eﬃcient membrane insertapoptosis. Of note, the microinjection of antibodies directed
against TOM20 as well as that of other mitochondrial outer
membrane proteins (e.g. metaxins or PBR) did not alter
mBaxtBid- and dBax-induced apoptosis (data not shown).
3.3. The insertion of Baxa can drive that of a mutant of Bax,
unable to interact with mitochondria
The above results suggest that TOM proteins are involved
only in the early steps of mBaxtBid incorporation but not in
that of dBax. Recently, Tan et al. [19] have proposed a mech-
anism in which liposome-bound Bax could directly activate
soluble Bax. To substantiate this hypothesis, we used an exper-
imental set up in which rat liver mitochondria were incubated
with mBaxtBid and a His-tagged Bax mutant (i.e. BaxL26G
HisTag), which is unable to interact with mitochondria [9]. As
illustrated in Fig. 3A, the BaxL26GHisTag was unable to asso-
ciate with mitochondria even in the presence of tBid, contrary
to mBax. However, in the presence of membrane-embedded
mBax, the BaxL26GHisTag was present in the mitochondrial
pellet and in an alkaline-resistant conformation. These results
suggest that mBaxtBid, once inserted into mitochondria, could
act as a receptor for BaxL26G. This insertion was dependent
on the BH3 domain of Bax, and thus on Bax oligomerization,
since a peptide derived from the BH3 domain of Bax (BH3Bax)
but not the corresponding L63E mutant (i.e. mBH3Bax), pre-
vented the association of BaxL26GHisTag to mitochondria
(Fig. 3A). Of note, the co-incubation of dBax with the
BaxL26GHisTag construct did not trigger the insertion of the
mutant into mitochondrial membranes (Fig. 3A). These results
suggest that mBaxtBid acts as a receptor for BaxL26G recruit-
ment to mitochondria. It has been shown that once inserted
into mitochondrial, Bax was resistant to mild protease
treatments [20,21]. A proteinase K treatment of mitochon-
drial-inserted mBaxtBid did not completely abrogate the bind-
ing of BaxL26GHisTag to the mitochondria (Fig. S2),
strengthening the idea that membrane embedded Bax could
be used as a receptor for the import-deﬁcient BaxL26G mu-
tant. The physical interaction between BaxL26G and Baxax is present as an inactive monomer in the cytoplasm of healthy cells.
liberates its mitochondrial-addressing signal, Ha1. At this stage, Bax is
22. Once inserted into the membrane, possibly through its interaction
s mechanism would allow a rapid and speciﬁc oligomerization into the
s. (B) The requirement for TOM22 can be bypassed by prior cytosolic
ion of Bax.
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formed under the diﬀerent conditions described above between
[35S]IVT-mBaxtBid or dBax and BaxL26GHisTag (Fig. 3B and
C). BaxL26GHisTag was detected using an anti-His antibody
and associated with mBaxtBid but not with dBax (Fig. 3B).
The co-immunoprecipitation of BaxL26GHisTag with mBaxtBid
was inhibited by a peptide BH3Bax and not by the peptide
mBH3Bax (Fig. 3C). In addition, TOM40 was detected using
an anti-His antibody only in the presence of mBaxtBid (Fig.
3C). These results show that BaxL26GHisTag physically associ-
ates with mBaxtBid and TOM40 to insert into the mitochondria
and cannot insert alone (Fig. 4).
Next, we analyze whether the in vitro redistribution of Bax
from the cytoplasm to the mitochondria could prompt that
of BaxL26G. To do this, BdGBM, a cell line lacking the
expression of endogenous Bax [12], were transfected either
with plasmids encoding for a ﬂag-tagged Bax construct (i.e.
BaxFlag) or the BaxL26GHisTag construct. As illustrated in
Fig. 3D, the BaxFlag redistribution from the cytoplasm to the
mitochondria was progressive after 5 h of apoptotic induction
using staurosporine (20 lM STS). On the other hand, the
mitochondrial localization of BaxL26GHisTag was found only
6–9 h after the induction of apoptosis in cells expressing
BaxFlag (Fig. 3D) and not observed in mock-transfected
BdGBM cells (data not shown). The mitochondrial association
of BaxL26GHisTag occurred via its interaction with BaxFlag as
immunoprecipitation with anti-Flag antibody detected a Bax-
Flag/BaxL26GHisTag in the mitochondrial fraction while no
BaxFlag/BaxL26GHisTag interactions were observed in the cyto-
plasm under similar conditions (Fig. 3D).4. Discussion
The critical event in Bax function is the transition from a
cytosolic monomer to membrane-embedded oligomers [3].
Here, we show that mBaxtBid but not dBax use the mammalian
TOM complex to associate with mitochondria (Fig. 1). In our
work, the dimerization of Bax was induced by modiﬁcation in
the pH, which faithfully reproduces the major changes in con-
formation of the pro-apoptotic protein that are observed dur-
ing apoptosis [10]. Cytosolic dBax could interact directly with
the lipid bilayer, as a trypsin treatment did not aﬀect its mito-
chondrial association (Fig. 2A and B). However, the mem-
brane insertion of dBax appears to be less complete than
that of mBax as it is less eﬃcient in the release of cyt c (Fig.
1D). Taken together, our results suggest that the interaction
of mBaxtBid with TOM plays a role not only in the addressing
but also in its ‘‘proper’’ membrane integration. This TOM-as-
sisted Bax insertion into mitochondria could thus be critical
for the transition from a monomeric to an oligomeric struc-
ture. This point is consistent with the idea that the eﬃcient
oligomerization of Bax occurs at the mitochondrial level rather
than in cytosol (see, for example, Ref. [7]).
In this work, we also show that once inserted into the mem-
brane, Bax can be used as receptor for other Bax molecules
and as such promote its insertion in a self-catalyzed fashion.
Quite interestingly, an autocatalytic assembly following a
receptor-mediated association to mitochondria has been de-
scribed for two other pores of the outer membrane, TOM40
and the mitochondrial porin, VDAC [22]. This type of mecha-
nism accelerates the insertion by many orders of magnitudecompared to a mechanism involving only lipid or receptor-
mediated insertion [22]. This type of autocatalytic insertion,
which has been also suggested by Tan et al. [19], would cer-
tainly represent an important step in the kinetics and ampliﬁ-
cation of the apoptotic signal triggered by Bax. The precise
involvement of the TOM complex along the apoptotic path-
way, in terms of the mechanisms and in the context of diﬀerent
physiological situations, remains to be determined. This
hypothesis does not preclude the involvement of non-protein
partners such as lipids, which could act on Bax membrane
insertion/permeabilization processes rather than on its mito-
chondrial association step [21,23].
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